Nextleaf Solutions Ltd. (CNSX: OILS)
Health Care · Pharmaceuticals · CA
CA$0.04
-22.22% today · -46.2% 1Y
Nextleaf Solutions Ltd. (CNSX: OILS) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $4.32M and employs 26 people.
Over the last twelve months the share price has lost 46.2%, trading between 0.04 and 0.09.
Tweenvest scores Nextleaf Solutions Ltd. across four factors: quality 63/100, value 61/100, growth 100/100. Its strongest factor is growth.
OILS price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $4.32M
- Revenue (TTM)
- $7.37M
- P/E
- —
- EPS
- -0.01
- Dividend yield
- —
- Beta (5Y)
- 0.91
- 52-week high
- CA$0.09
- 52-week low
- CA$0.04
- Avg volume (3M)
- —
- Shares outstanding
- 169.94M
- Employees
- 26
- Next earnings
- —
About Nextleaf Solutions Ltd.
Nextleaf Solutions Ltd. operates as a cannabis extraction technology enterprise, pioneering and licensing advanced methods for the processing, refinement, and development of cannabinoid formulations throughout Canada. The company is actively involved in the extraction, distillation, and purification of CBD oils and THC ingredients, which it subsequently distributes and sells wholesale. Its operations further encompass comprehensive research and development for cannabis-infused products, including vaporizers, edible concentrates, and specialized extracts, in addition to providing expert extraction services. Nextleaf also dedicates efforts to the creation and market introduction of psychoactive compounds. Established in 2015, the firm is headquartered in Vancouver, Canada, and was previously known as Legion Metals Corp.
- ISIN
- CA65347A1021
- Founded
- 2015
- Listed since
- Sep 18, 2017
- Exchange
- Canadian National Stock Exchange
- Currency
- CAD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,213.74 | -1.61% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $270.87 | -0.83% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $154.50 | -1.25% |
| Roche Holding AGSWX: ROP | $371.62B | CHF369.90 | -1.04% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £122.60 | -1.73% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.29 | -0.98% |
Figures last refreshed Aug 18, 2026.